Concurrent Identification of Novel EGFR–SEPT14 Fusion and ETV6–RET Fusion in Secretory Carcinoma of the Salivary Gland
- 9 September 2019
- journal article
- case report
- Published by Springer Nature in Head and Neck Pathology
- Vol. 14 (3) , 817-821
Abstract
Salivary gland secretory carcinoma, also termed mammary analogue secretory carcinoma (MASC), is a recently described salivary gland neoplasm with characteristic histomorphologic findings similar to those of secretory carcinoma of the breast and harboring recurrent ETV6–NTRK3 fusions. Recent findings have expanded the molecular profile of salivary gland secretory carcinoma to include multiple novel ETV6 fusion partners, including RET, MET, and MAML3. Here, we report a case of cystic MASC with cribriform and papillary histology harboring two gene fusions, ETV6–RET and EGFR–SEPT14, identified by targeted RNA sequencing. The presence of the rearrangements was confirmed by FISH, RT-PCR, and Sanger sequencing. This is the first EGFR–SEPT14 fusion reported in secretory carcinoma as a single event or in association with an ETV6 rearrangement. This finding adds to the expanding molecular profile of this tumor entity, and may translate into novel treatment strategies.Keywords
This publication has 20 references indexed in Scilit:
- Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 familyHuman Pathology, 2019
- Salivary Secretory Carcinoma With a Novel ETV6-MET FusionAmerican Journal of Surgical Pathology, 2018
- Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET TranslocationAmerican Journal of Surgical Pathology, 2018
- Mammary Analogue Secretory Carcinoma of Salivary GlandsAmerican Journal of Surgical Pathology, 2016
- Mammary Analogue Secretory Carcinoma of Salivary GlandsAmerican Journal of Surgical Pathology, 2015
- GATA3 Immunohistochemical Expression in Salivary Gland NeoplasmsHead and Neck Pathology, 2013
- Mammary analog secretory carcinoma of salivary glands: A report of 2 cases with expression of basal/myoepithelial markers (calponin, CD10 and p63 protein)Pathology - Research and Practice, 2013
- Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor EntityAmerican Journal of Surgical Pathology, 2010
- Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistryHuman Pathology, 2003
- Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinomaCancer Cell, 2002